Your browser doesn't support javascript.
loading
Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
Raizada, Neeraj; Sachdeva, Kuldeep Singh; Nair, Sreenivas Achuthan; Kulsange, Shubhangi; Gupta, Radhey Shayam; Thakur, Rahul; Parmar, Malik; Gray, Christen; Ramachandran, Ranjani; Vadera, Bhavin; Ekka, Shobha; Dhawan, Shikha; Babre, Ameet; Ghedia, Mayank; Alavadi, Umesh; Dewan, Puneet; Khetrapal, Mini; Khanna, Ashwini; Boehme, Catharina; Paramsivan, Chinnambedu Nainarappan.
Afiliação
  • Raizada N; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Sachdeva KS; Central TB Division, Government of India, New Delhi, India.
  • Nair SA; World Health Organization, Country Office for India, New Delhi, India.
  • Kulsange S; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Gupta RS; Central TB Division, Government of India, New Delhi, India.
  • Thakur R; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Parmar M; World Health Organization, Country Office for India, New Delhi, India.
  • Gray C; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Ramachandran R; World Health Organization, Country Office for India, New Delhi, India.
  • Vadera B; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Ekka S; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Dhawan S; Central TB Division, Government of India, New Delhi, India.
  • Babre A; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Ghedia M; World Health Organization, Country Office for India, New Delhi, India.
  • Alavadi U; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Dewan P; World Health Organization, Country Office for India, New Delhi, India.
  • Khetrapal M; District Tuberculosis Center, Mumbai, India.
  • Khanna A; District Tuberculosis Center, New Delhi, India.
  • Boehme C; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Paramsivan CN; Foundation for Innovative New Diagnostics, New Delhi, India.
PLoS One ; 9(8): e105346, 2014.
Article em En | MEDLINE | ID: mdl-25140877
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn Idioma: En Ano de publicação: 2014 Tipo de documento: Article